Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants**Supported by GAPS 8516 and 8815 from The Rockefeller Foundation, New York, New York, and the United States Agency for International Development, the George J. Hecht Fund, the Andrew W. Mellon Foundation, and the United Nations Population Fund, New York, New York.
1991 ◽
Vol 56
(1)
◽
pp. 27-31
◽
1991 ◽
Vol 56
(3)
◽
pp. 440-445
◽
1990 ◽
Vol 53
(5)
◽
pp. 898-905
◽
1987 ◽
Vol 47
(6)
◽
pp. 1010-1018
◽
1992 ◽
Vol 58
(4)
◽
pp. 680-684
◽
1984 ◽
Vol 41
(5)
◽
pp. 726-731
◽
1992 ◽
Vol 58
(6)
◽
pp. 1142-1147
◽
2014 ◽
Vol 1
(2)
◽
pp. 63-70
◽
2017 ◽
Vol 36
(4)
◽
pp. 719-738
◽
2018 ◽
Vol 50
(3)
◽
pp. 513-536
◽
1993 ◽
Vol 60
(3)
◽
pp. 533-539
◽